Logo image of BZUN

BAOZUN INC-SPN ADR (BZUN) Stock Fundamental Analysis

NASDAQ:BZUN - Nasdaq - US06684L1035 - ADR - Currency: USD

3.05  +0.05 (+1.67%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BZUN. BZUN was compared to 31 industry peers in the Broadline Retail industry. BZUN may be in some trouble as it scores bad on both profitability and health. BZUN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

BZUN had negative earnings in the past year.
In the past year BZUN had a positive cash flow from operations.
In the past 5 years BZUN reported 4 times negative net income.
Of the past 5 years BZUN 4 years had a positive operating cash flow.
BZUN Yearly Net Income VS EBIT VS OCF VS FCFBZUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M -600M

1.2 Ratios

BZUN has a Return On Assets (-1.82%) which is comparable to the rest of the industry.
The Return On Equity of BZUN (-4.75%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.82%
ROE -4.75%
ROIC N/A
ROA(3y)-3.64%
ROA(5y)-1.73%
ROE(3y)-9.17%
ROE(5y)-5.01%
ROIC(3y)N/A
ROIC(5y)N/A
BZUN Yearly ROA, ROE, ROICBZUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

BZUN's Gross Margin of 73.74% is amongst the best of the industry. BZUN outperforms 96.77% of its industry peers.
In the last couple of years the Gross Margin of BZUN has grown nicely.
The Profit Margin and Operating Margin are not available for BZUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.23%
GM growth 5Y3.57%
BZUN Yearly Profit, Operating, Gross MarginsBZUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

BZUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BZUN has less shares outstanding
Compared to 5 years ago, BZUN has less shares outstanding
BZUN has a worse debt/assets ratio than last year.
BZUN Yearly Shares OutstandingBZUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BZUN Yearly Total Debt VS Total AssetsBZUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

BZUN has an Altman-Z score of 1.32. This is a bad value and indicates that BZUN is not financially healthy and even has some risk of bankruptcy.
BZUN has a worse Altman-Z score (1.32) than 61.29% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that BZUN is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.43, BZUN perfoms like the industry average, outperforming 45.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACCN/A
WACC7.01%
BZUN Yearly LT Debt VS Equity VS FCFBZUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

BZUN has a Current Ratio of 1.92. This is a normal value and indicates that BZUN is financially healthy and should not expect problems in meeting its short term obligations.
BZUN's Current ratio of 1.92 is fine compared to the rest of the industry. BZUN outperforms 64.52% of its industry peers.
BZUN has a Quick Ratio of 1.63. This is a normal value and indicates that BZUN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.63, BZUN is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.63
BZUN Yearly Current Assets VS Current LiabilitesBZUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

3

3. Growth

3.1 Past

BZUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.54%.
Looking at the last year, BZUN shows a small growth in Revenue. The Revenue has grown by 6.92% in the last year.
Measured over the past years, BZUN shows a small growth in Revenue. The Revenue has been growing by 5.30% on average per year.
EPS 1Y (TTM)-28.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-288.24%
Revenue 1Y (TTM)6.92%
Revenue growth 3Y0.09%
Revenue growth 5Y5.3%
Sales Q2Q%4.27%

3.2 Future

Based on estimates for the next years, BZUN will show a very strong growth in Earnings Per Share. The EPS will grow by 87.85% on average per year.
BZUN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.45% yearly.
EPS Next Y210.9%
EPS Next 2Y109.47%
EPS Next 3Y101.34%
EPS Next 5Y87.85%
Revenue Next Year4.37%
Revenue Next 2Y4.2%
Revenue Next 3Y4.43%
Revenue Next 5Y4.45%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BZUN Yearly Revenue VS EstimatesBZUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
BZUN Yearly EPS VS EstimatesBZUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BZUN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 12.87, which indicates a correct valuation of BZUN.
Based on the Price/Forward Earnings ratio, BZUN is valued a bit cheaper than 70.97% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BZUN to the average of the S&P500 Index (21.76), we can say BZUN is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 12.87
BZUN Price Earnings VS Forward Price EarningsBZUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

67.74% of the companies in the same industry are more expensive than BZUN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.25
BZUN Per share dataBZUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BZUN's earnings are expected to grow with 101.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y109.47%
EPS Next 3Y101.34%

More info and screens

0

5. Dividend

5.1 Amount

BZUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAOZUN INC-SPN ADR

NASDAQ:BZUN (5/23/2025, 9:17:28 PM)

3.05

+0.05 (+1.67%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-26 2025-08-26
Inst Owners20.2%
Inst Owner Change-5.7%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap178.77M
Analysts83.33
Price Target3.72 (21.97%)
Short Float %5.64%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-152.26%
Min EPS beat(2)-346.95%
Max EPS beat(2)42.43%
EPS beat(4)1
Avg EPS beat(4)-351.66%
Min EPS beat(4)-986.96%
Max EPS beat(4)42.43%
EPS beat(8)3
Avg EPS beat(8)-320.25%
EPS beat(12)3
Avg EPS beat(12)-238.48%
EPS beat(16)6
Avg EPS beat(16)-261.34%
Revenue beat(2)2
Avg Revenue beat(2)6.63%
Min Revenue beat(2)0.42%
Max Revenue beat(2)12.85%
Revenue beat(4)3
Avg Revenue beat(4)2.54%
Min Revenue beat(4)-4.21%
Max Revenue beat(4)12.85%
Revenue beat(8)3
Avg Revenue beat(8)-0.56%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)4
Avg Revenue beat(16)-1.79%
PT rev (1m)0%
PT rev (3m)6.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-168.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.87
P/S 0.14
P/FCF N/A
P/OCF 12.75
P/B 0.33
P/tB 0.4
EV/EBITDA 9.25
EPS(TTM)-0.2
EYN/A
EPS(NY)0.24
Fwd EY7.77%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0.24
OCFY7.84%
SpS22.31
BVpS9.27
TBVpS7.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.82%
ROE -4.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.74%
FCFM N/A
ROA(3y)-3.64%
ROA(5y)-1.73%
ROE(3y)-9.17%
ROE(5y)-5.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.23%
GM growth 5Y3.57%
F-Score7
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Debt/EBITDA 12.28
Cap/Depr 84.9%
Cap/Sales 2.21%
Interest Coverage N/A
Cash Conversion 73.72%
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.63
Altman-Z 1.32
F-Score7
WACC7.01%
ROIC/WACCN/A
Cap/Depr(3y)102.69%
Cap/Depr(5y)116.63%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-288.24%
EPS Next Y210.9%
EPS Next 2Y109.47%
EPS Next 3Y101.34%
EPS Next 5Y87.85%
Revenue 1Y (TTM)6.92%
Revenue growth 3Y0.09%
Revenue growth 5Y5.3%
Sales Q2Q%4.27%
Revenue Next Year4.37%
Revenue Next 2Y4.2%
Revenue Next 3Y4.43%
Revenue Next 5Y4.45%
EBIT growth 1Y36.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year330.64%
EBIT Next 3Y79.65%
EBIT Next 5Y61.58%
FCF growth 1Y-149.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-77.46%
OCF growth 3YN/A
OCF growth 5Y-19.64%